Compare IPEX & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPEX | OXSQ |
|---|---|---|
| Founded | 2024 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.5M | 137.5M |
| IPO Year | N/A | N/A |
| Metric | IPEX | OXSQ |
|---|---|---|
| Price | $10.54 | $1.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.4K | ★ 1.5M |
| Earning Date | 04-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 22.83% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $41.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.25 | $1.05 |
| 52 Week High | $10.54 | $2.42 |
| Indicator | IPEX | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 68.70 | 51.03 |
| Support Level | $10.42 | $1.26 |
| Resistance Level | N/A | $1.95 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 100.00 | 50.00 |
Inflection Point Acquisition Corp V is a blank check company.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize portfolio's total return. Its primary current focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and, to a lesser extent collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. CLO investments may also include warehouse facilities, which are early-stage CLO vehicles intended to aggregate loans that may be used to form the basis of a traditional CLO vehicle. The company may also invest in publicly traded debt and/or equity securities.